# DOJ Resolves California NIH Grant Allegations

Cyion Technologies LLC, a Pleasanton, California biotech company, agreed to pay $528,335.74 to resolve allegations that it improperly obtained and drew down National Institutes of Health (NIH) Small Business Innovation Research and Small Business Technology Transfer grant funds while its principal investigator held undisclosed outside full-time employment. The matter involved two STTR awards and one SBIR award; the settlement resolves allegations and is not a determination of liability. For procurement professionals and research-grant recipients, it underscores the importance of accurate eligibility disclosures and compliance with personnel restrictions tied to federal funding.

- Federal SBIR/STTR recipients must follow applicable grant conditions, including restrictions on outside full-time employment, and ensure disclosures about key personnel are accurate.
- Companies managing research awards should review how investigator employment and eligibility information is documented and reported, as grant compliance issues can lead to False Claims Act enforcement and financial settlements.
- The awards were associated with STTR applications in 2017 and an SBIR application in 2023; the settlement amount is not the value of those awards.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding, Regulatory Compliance
**Published:** November 16, 2026

### Government Entities
- National Institutes of Health (NIH)
- U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG)
- U.S. Attorney’s Office for the Northern District of California (USAO-NDCA)
- U.S. Department of Justice (DOJ)

### Vendors
- Cyion Technologies LLC (federal grant recipient)

### Key Quotes
> The requirements governing these grants, including restrictions on outside full-time employment, are not optional. When companies misrepresent their eligibility to obtain federal funding, my office will vigorously enforce the False Claims Act to hold them accountable and protect taxpayer dollars.
> — Craig H. Missakian, United States Attorney

### Sources
- [Pleasanton Biotech Company Agrees to Pay Over a Half Million to Resolve Allegations That It Improperly Obtained Federal Grant Funds](https://goldrushcam.com/sierrasuntimes/index.php/news/california/83505-pleasanton-biotech-company-agrees-to-pay-over-a-half-million-to-resolve-allegations-that-it-improperly-obtained-federal-grant-funds) - Sierra Sun Times